Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesoblast (MESO) Other Accumulated Expenses: 2016-2024

Historic Other Accumulated Expenses for Mesoblast (MESO) over the last 3 years, with Jun 2024 value amounting to $385,000.

  • Mesoblast's Other Accumulated Expenses rose 4.90% to $385,000 in Q2 2024 from the same period last year, while for Jun 2024 it was $385,000, marking a year-over-year increase of 4.90%. This contributed to the annual value of $385,000 for FY2024, which is 4.90% up from last year.
  • According to the latest figures from Q2 2024, Mesoblast's Other Accumulated Expenses is $385,000, which was up 4.90% from $367,000 recorded in Q2 2023.
  • Mesoblast's 5-year Other Accumulated Expenses high stood at $1.8 million for Q2 2021, and its period low was $367,000 during Q2 2023.
  • Its 3-year average for Other Accumulated Expenses is $668,667, with a median of $385,000 in 2024.
  • Per our database at Business Quant, Mesoblast's Other Accumulated Expenses soared by 75.12% in 2021 and then tumbled by 70.73% in 2023.
  • Quarterly analysis of 5 years shows Mesoblast's Other Accumulated Expenses stood at $1.0 million in 2020, then soared by 75.12% to $1.8 million in 2021, then fell by 28.75% to $1.3 million in 2022, then tumbled by 70.73% to $367,000 in 2023, then increased by 4.90% to $385,000 in 2024.
  • Its Other Accumulated Expenses was $385,000 in Q2 2024, compared to $367,000 in Q2 2023 and $1.3 million in Q2 2022.